Literature DB >> 6734425

Transdermal administration of nicotine.

J E Rose, M E Jarvik, K D Rose.   

Abstract

The physiological response to nicotine topically applied to the skin was measured in an adult male volunteer. Nicotine base (9 mg) was applied in a 30% aqueous solution to intact skin on the underside of the forearm. Salivary nicotine, heart rate and blood pressure were monitored for 12 h after application of the nicotine. Within 30 min a significant level of nicotine was detected in the saliva (50 ng/ml), pulse had risen by 15 beats/min and systolic blood pressure had risen 10 mmHg. Nicotine levels remained elevated for 2 h and were comparable to levels of nicotine produced by cigarette smoking. Because previous research has shown nicotine to suppress smoking behavior, it may be fruitful to examine transdermal administration of nicotine as a smoking reduction and cessation aid.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734425     DOI: 10.1016/0376-8716(84)90061-9

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  13 in total

1.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

2.  Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.

Authors:  H D Ross; K K Chan; A J Piraino; V A John
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

3.  Concentration dependency in nicotine skin penetration flux from aqueous solutions reflects vehicle induced changes in nicotine stratum corneum retention.

Authors:  Rina Kuswahyuning; Michael S Roberts
Journal:  Pharm Res       Date:  2014-01-23       Impact factor: 4.200

4.  Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study.

Authors:  Y B Bannon; J Corish; O I Corrigan; J G Devane; M Kavanagh; S Mulligan
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

6.  The delivery and uptake of nicotine from an aerosol rod.

Authors:  D W Sepkovic; S G Colosimo; C M Axelrad; J D Adams; N J Haley
Journal:  Am J Public Health       Date:  1986-11       Impact factor: 9.308

Review 7.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

8.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Clinical pharmacokinetics of nicotine.

Authors:  C K Svensson
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

10.  Nicotine-mediated signals modulate cell death and survival of T lymphocytes.

Authors:  Silvia C S Oloris; Ashley A Frazer-Abel; Cristan M Jubala; Susan P Fosmire; Karen M Helm; Sally R Robinson; Derek M Korpela; Megan M Duckett; Shairaz Baksh; Jaime F Modiano
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-04       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.